Sexual behavior and infection with cervical human papillomavirus types 16 and 18

References

• Bosch FX, De Sanjosé S. Chapter 1: human papillomavirus and cervical cancer – burden and assessment of causality. JNCI Monogr. 2003;2003(31):3–13. doi:10.1093/oxfordjournals.jncimonographs.a003479
   Google Scholar
• Siriaunkgul S, Suwiwat S, Settakorn J, et al. HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol. 2008;108(3):555–560. doi:10.1016/j.ygyno.2007.11.01618199473
   PubMed Web of Science ®Google Scholar
• Siriaunkgul S, Utaipat U, Settakorn J, Sukpan K, Srisomboon J, Khunamornpong S. HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand. Int J Gynecol Obstet. 2011;115(2):175–179. doi:10.1016/j.ijgo.2011.06.010
   Web of Science ®Google Scholar
• Siriaunkgul S, Utaipat U, Suthipintawong C, Tungsinmunkong K, Triratanachat S, Khunamornpong S. HPV genotyping in adenocarcinoma of the uterine cervix in Thailand. Int J Gynecol Obstet. 2013;123(3):226–230. doi:10.1016/j.ijgo.2013.06.034
   Web of Science ®Google Scholar
• Alemany L, De Sanjosé S, Tous S, et al. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer. 2014;135(1):88–95. doi:10.1002/ijc.2863624382655
   PubMed Web of Science ®Google Scholar
• Kietpeerakool C, Kleebkaow P, Srisomboon J. Human papillomavirus genotype distribution among Thai women with high-grade cervical intraepithelial lesions and invasive cervical cancer: a literature review. Asian Pac J Cancer Prev. 2015;16(13):5153–5158. doi:10.7314/apjcp.2015.16.13.515326225645
   PubMedGoogle Scholar
• Schiffman M, Burk RD, Boyle S, et al. A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results. J Clin Microbiol. 2015;53(1):52–59. doi:10.1128/JCM.02116-1425339396
   PubMed Web of Science ®Google Scholar
• Silver MI, Andrews J, Cooper CK, et al. Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16/18, and colposcopy impression: a systematic review and meta-analysis. Obstet Gynecol. 2018;132(3):725–735. doi:10.1097/AOG.000000000000281230095780
   PubMed Web of Science ®Google Scholar
• Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. J Clin Virol. 2016;76:S49–S55. doi:10.1016/j.jcv.2015.11.01526643050
   PubMed Web of Science ®Google Scholar
• Kietpeerakool C, Tangjitgamol S, Srisomboon J. Histopathological outcomes of women with abnormal cervical cytology: a review of literature in Thailand. Asian Pac J Cancer Prev. 2014;15(16):6489–6494. doi:10.7314/APJCP.2014.15.16.648925169475
   PubMedGoogle Scholar
• Paengchit K, Kietpeerakool C, Wangchai W, Pouraeng S, Lalitwongsa S. Cervical pathology in cytology-negative/HPV-positive women: results from lampang cancer hospital, Thailand. Asian Pac J Cancer Prev. 2014;15(18):7951–7954. doi:10.7314/apjcp.2014.15.18.795125292093
   PubMedGoogle Scholar
• Supho B, Supoken A, Kleebkaew P, Kietpeerakool C. Cervical pathology in high-risk human papillomavirus-positive, cytologically normal women. Asian Pac J Cancer Prev. 2014;15(18):7977–7980. doi:10.7314/APJCP.2014.15.18.797725292098
   PubMedGoogle Scholar
• Baudu A, Prétet J-L, Riethmuller D, Chotard M, Mougin C, Mercier M. Prevalence and risk factors of human papillomavirus infection types 16/ 18/45 in a cohort of French females aged 15–23 years. J Epidemiol Glob Health. 2014;4(1):35–43. doi:10.1016/j.jegh.2013.11.00324534334
   PubMedGoogle Scholar
• Rudolph SE, Lorincz A, Wheeler CM, et al. Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico. BMC Infect Dis. 2016;16(1):461. doi:10.1186/s12879-016-1987-z27585544
   PubMed Web of Science ®Google Scholar
• Shields TS, Brinton LA, Burk RD, et al. A case-control study of risk factors for invasive cervical cancer among US women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Prev Biomarkers. 2004;13(10):1574–1582.
   Web of Science ®Google Scholar
• Porras C, Bennett C, Safaeian M, et al. Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis. 2010;10(1):238. doi:10.1186/1471-2334-10-23820698998
   PubMed Web of Science ®Google Scholar
• Ryser MD, Rositch A, Gravitt PE. Modeling of US human papillomavirus (HPV) seroprevalence by age and sexual behavior indicates an increasing trend of HPV infection following the sexual revolution. J Infect Dis. 2017;216(5):604–611. doi:10.1093/infdis/jix33328931221
   PubMed Web of Science ®Google Scholar
• Coseo S, Porras C, Hildesheim A, et al. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. Sex Transm Dis. 2010;37(11):706–714. doi:10.1097/OLQ.0b013e3181e1a2c520661178
   PubMed Web of Science ®Google Scholar
• Kim S, Arduino JM, Roberts CC, Marsico M, Liaw K-L, Skjeldestad FE. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young Norwegian women. Sex Transm Dis. 2011;38(7):587–597. doi:10.1097/OLQ.0b013e31820a932421301390
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958–964. doi:10.1093/jnci/85.12.9588388478
   PubMed Web of Science ®Google Scholar
• Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327(18):1272–1278. doi:10.1056/NEJM1992102932718041328880
   PubMed Web of Science ®Google Scholar
• Burger EA, Kim JJ, Sy S, Castle PE. Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin Infect Dis. 2017;65(6):893–899. doi:10.1093/cid/cix47528531261
   PubMed Web of Science ®Google Scholar
• Khunamornpong S, Settakorn J, Sukpan K, et al. Genotyping for human papillomavirus (HPV) 16/18/52/58 has a higher performance than HPV16/18 genotyping in triaging women with positive high-risk HPV test in Northern Thailand. PLoS One. 2016;11(6):e0158184. doi:10.1371/journal.pone.015818427336913
   PubMed Web of Science ®Google Scholar
• Wang R, Guo X, Wisman GBA, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015;15(1):257. doi:10.1186/s12879-015-0998-526142044
   PubMed Web of Science ®Google Scholar
• Carozzi F, De Marco L, Gillio-Tos A, et al. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence. J Clin Virol. 2014;60(3):257–263. doi:10.1016/j.jcv.2014.04.00924815381
   PubMed Web of Science ®Google Scholar
• Schabath MB, Villa LL, Lazcano-Ponce E, Salmerón J, Quiterio M, Giuliano AR. Smoking and human papillomavirus (HPV) infection in the HPV in men (HIM) study. Cancer Epidemiol Prev Biomarkers. 2012;21(1):102–110. doi:10.1158/1055-9965.EPI-11-0591
   Web of Science ®Google Scholar